MULTIPLE SCLEROSIS

MULTIPLE SCLEROSIS REFERRAL FORM Today's Date Anticipated Start Date
314 E 204th St., Bronx, NY 10467 November 21, 2024
Phone: 718-882-5614   Fax: 718-882-6365

Patient Name Date Of Birth Weight Gender
Street Address Apartment # City State Zip
Daytime Telephone Evening Telephone Cellphone Email Address
Ship To Patient At Date Needed
    OR Patient will pick up at  
ICD-9 CODE Diagnosis Allergies
Testing Results Patient Currently on Therapy Date of Next Blood Work
   

Insured's Name Relation to Patient Eligible for Medicare If yes, Medicare #
 
Prescription Card If Yes, Carrier Telephone Fax Number Policy/Group #
 
BIN # PCN # RXID # RX Group #

Prescriber's Name Office Contact
Street Address Suite # City State Zip
Telephone Fax Number Email Address
License # NPI # UPIN # DEA #
Prescription PLEASE ATTACH COPIES OF PATIENT'S INSURANCE CARDS
AVONEX ADMINISTRATION PACK 30mcg PreFilled
SIG
Inject 30mcg IM once weekly Other
QTY # of Weeks (1 pack = 4 week supply)
Refills X
BETASERON 0.3mg Vials
SIG
Inject SC every other day Other
QTY # of Weeks (1 box = 4 week supply)
Refills X
COPAXONE
40mg/ml Syringe
SIG
Inject 40mg SC three times weekly Other
20mg/ml Syringe
SIG
Inject 20mg SC once daily Other
QTY # of Syringes
Refills X
EXTAVIA VIALS
SIG
Inject SC every other day Other
QTY # of Weeks (1 box = 4 week supply) Refills X
REBIF TITRATION PACK 12 syringes
SIG
8.8mcg SQ TIW - weeks 1 & 2
Maintenance Dose following week 3 & 4
22mcg SQ TIW - weeks 3 & 4
QTY # of Boxes (1 box = 4 week supply) Refills X
REBIF 22mcg/0.5ml
SIG 22mg (0.5ml) SQ TIW (48hrs apart)
QTY # of Boxes (1 box = 4 week supply) Refills X
REBIF 44mcg/0.5ml (Maintenance)
SIG Starting wk 5: 44mcg (0.5ml) SQ TIW (48hrs apart)
QTY # of Boxes (1 box = 4 week supply) Refills X
OTHER
SIG QTY Refills x
GILENYA
0.5 mg # orally once daily QTY - 28
Refills x

Prescriber's SignatureDate: November 21, 2024

IMPORTANT NOTICE: This form is intentded to be delivered only to the named addressee. It contains material that is confidential, privilaeged, proprietary or exempt from disclosure under applicable law. IF you are not the named addressee, you should not disseminate, distribute, or copy this fax. Please notify the sender immediately if you have received this document in error and then destroy this document immediately.